{"podcast":{"title":"A Health Podyssey","slug":"a-health-podyssey-1366621","podcast_index_feed_id":1366621,"rss_url":"https://feeds.transistor.fm/a-health-podyssey","website_url":"https://www.healthaffairs.org/podcasts","image_url":"https://img.transistorcdn.com/CA0GVoNR-7-repgsjaV9h8eCWrF2C-P6WydGA5djdoE/rs:fill:0:0:1/w:1400/h:1400/q:60/mb:500000/aHR0cHM6Ly9pbWct/dXBsb2FkLXByb2R1/Y3Rpb24udHJhbnNp/c3Rvci5mbS9zaG93/LzE0ODU4LzE2MDE0/MDI1NzEtYXJ0d29y/ay5qcGc.jpg","author":"Health Affairs","episode_count":300,"summary":"Each week, Health Affairs' Rob Lott brings you in-depth conversations with leading researchers and influencers shaping the big ideas in health policy and the health care industry. A Health Podyssey goes beyond the pages of the health policy journal Health Affairs to tell stories behind the research and share policy implications. Learn how academics and economists frame their research questions and journey to the intersection of health, health care, and policy. Health policy nerds rejoice! This podcast is for you.","last_synced_at":"2026-06-09T14:18:31.789919+00:00","page_url":"https://stenobird.com/podcast/a-health-podyssey-1366621"},"episode":{"title":"What Most Favored Nation Drug Pricing Would Mean for the US","slug":"what-most-favored-nation-drug-pricing-would-mean-for-the-us","published_at":"2026-04-14T04:00:00+00:00","page_url":"https://stenobird.com/podcast/a-health-podyssey-1366621/what-most-favored-nation-drug-pricing-would-mean-for-the-us","show_page_url":"https://stenobird.com/podcast/a-health-podyssey-1366621","url":"https://share.transistor.fm/s/364cdcdb","audio_url":"https://media.transistor.fm/364cdcdb/fd8f0aae.mp3","summary":"Health Affairs ' Rob Lott interviews James Robinson of the University of California Berkeley about his recent paper exploring most favored nation drug pricing , weighing its feasibility, likely effects on drug launch prices, and implications for global pharmaceutical innovation and investment. Order the April 2026 issue of Health Affairs .","meta_description":"Health Affairs ' Rob Lott interviews James Robinson of the University of California Berkeley about his recent paper exploring most favored nation drug pri…","key_points":[],"chapters":[],"topics":[],"duration_seconds":1435,"processing_state":"not_requested","actions":[{"name":"request_transcript","method":"POST","url":"https://stenobird.com/v1/public/podcasts/a-health-podyssey-1366621/episodes/what-most-favored-nation-drug-pricing-would-mean-for-the-us/transcription-requests","description":"Idempotently request low-priority transcript generation for this episode."},{"name":"read_markdown","method":"GET","url":"https://stenobird.com/podcast/a-health-podyssey-1366621/what-most-favored-nation-drug-pricing-would-mean-for-the-us.md","description":"Read the agent-friendly Markdown representation of this episode resource."}]}}